JeffreyDavidLebensburgerDOMSPH

Pediatric Hematology & Oncology • Birmingham, AL

Professor, Pediatrics, University of Alabama at Birmingham School of Medicine

Join to view full profile

Dr. Lebensburger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lebensburger's full profile

Already have an account?

Office
1600 7th Ave S
Birmingham, AL 35233
Phone+1 205-939-5423

Summary

Dr Lebensburger is a board certified Pediatric Hematologist Oncologist. He specializes in Hematology with national expertise in SCD Nephropathy

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of Florida (Orlando)Residency, Pediatrics, 2003 - 2006
Nova Southeastern University College of Osteopathic MedicineClass of 2003

Certifications & Licensure

AL State License 2009 - 2025
WI State License 2014 - 2014
TN State License 2006 - 2009
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Scholar Award American Society of Hematology
Best Doctors in America Best Doctors

Clinical Trials

Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease Start of enrollment: 2012 Aug 16
Completed
Phase 2
Preventing Sickle Cell Kidney Disease Start of enrollment: 2015 Apr 01
Terminated
Phase 2
Acute Kidney Injury in Patients With Sickle Cell Disease Start of enrollment: 2017 Jan 01
Completed
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease Start of enrollment: 2017 Jun 02
Recruiting
Roles: Contact
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia Start of enrollment: 2021 May 12
Recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Emergency department intravenous fluid resuscitation and renal outcomes among adults with sickle cell disease.
Marcus A Carden, Jeffrey Lebensburger, Wayne Rosamond, Paula Tanabe, Vimal K Derebail
American Journal of Hematology. 2025-01-01
Pain-Related Injustice Appraisals, Sickle Cell Stigma, and Racialized Discrimination in the Youth with Sickle Cell Disease: A Preliminary Investigation.
Megan M Miller, Ama Kissi, Deanna D Rumble, Adam T Hirsh, Tine Vervoort
Journal of Racial and Ethnic Health Disparities. 2024-12-09
Biomarkers to Differentiate Acute Chest Syndrome From Vaso-Occlusive Crisis in Children With Sickle Cell Disease.
Karen Wang, Nelida Olave, Saurabh Aggarwal, Joo-Yeun Oh, Rakesh P Patel
European Journal of Haematology. 2024-11-05

Lectures

Impact of Hyperfiltration during Early Childhood on the Natural History of Albuminuria in Pediatric Sickle Cell Anemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

Outcomes in Mild to Moderate Isolated ThrombocytopeniaJuly 2018

Press Mentions

Priapism in Sickle Cell Disease: Associations Between NOS3 and EDN1 Genetic Polymorphisms and Laboratory BiomarkersFebruary 4th, 2021
Marijuana Use and Health Behaviors in a US Clinic Sample of Patients with Sickle Cell DiseaseJuly 14th, 2020
UAB - School of Medicine - PediatricsJune 25th, 2017

Grant Support

Chronobiology and Chronopharmacology to Prevent Sickle NephropathyNational Heart Lung Blood Institute2015–2019
Scholar AwardAmerican Society of Hematology2015–2018
Sickle Cell Aspire GrantPfizerPresent